#Mounjaro

A fitness influencer with more than five million followers has sparked a widespread ethics discussion in Thailand after revealing in a YouTube video that her recent weight loss benefited from a GLP-1 medication, not just diet and exercise. The video titled “Let’s talk: Therapy, GLP-1 & The Truth About My Recent Weight Loss” has prompted conversations about transparency and the responsibilities of online wellness creators.

The influencer previously promoted a popular $200 weight-loss course focused on macro tracking and lifestyle changes. She disclosed that, in addition to her usual methods, she used a GLP-1 medicine under medical supervision. She stressed that GLP-1s are not magic and that she continues to follow diet and exercise plans. Reactions among followers were mixed; some accused her of withholding information that could affect purchasing decisions and refunds.

A social media fitness influencer with over five million followers has ignited a widespread controversy after publicly sharing that her recent weight loss success involved the use of a GLP-1 class medication, commonly known by names such as Ozempic and Mounjaro. The disclosure, made in a YouTube video titled “Let’s talk: Therapy, GLP-1 & The Truth About My Recent Weight Loss,” has set off heated discussions about transparency, ethical responsibility, and the realities of the online wellness industry.